NASDAQ: CORT
Corcept Therapeutics Inc Stock Ownership - Who owns Corcept Therapeutics?

Insider buying vs selling

Have Corcept Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Hazel HuntChief Scientific Officer2025-02-11150,000$3.29
$493.50kBuy
Hazel HuntChief Scientific Officer2025-02-1185,176$68.11
$5.80MSell
Daniel N. Swisher Jr.Director2025-02-102,200$12.13
$26.69kBuy
Daniel N. Swisher Jr.Director2025-02-102,200$68.08
$149.78kSell
Joseph Douglas LyonChief Accounting Technology Officer2025-02-031,571$11.35
$17.83kBuy
Joseph Douglas LyonChief Accounting Technology Officer2025-02-033,429$13.56
$46.50kBuy
Sean MaduckOfficer2025-02-0311,986$3.88
$46.51kBuy
Joseph Douglas LyonChief Accounting Technology Officer2025-02-035,000$66.92
$334.60kSell
Sean MaduckOfficer2025-02-0320,000$66.92
$1.34MSell
Sean MaduckOfficer2025-02-038,014$5.05
$40.47kBuy

1 of 13

CORT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CORT insiders and whales buy or sell their stock.

CORT Shareholders

What type of owners hold Corcept Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick G. Enright42.76%44,802,403$3.26BInsider
Blackrock Inc14.96%15,677,327$1.14BInstitution
Bakker Juliet Tammenoms10.58%11,089,541$806.43MInsider
Longitude Venture Partners LP10.46%10,956,002$796.72MInsider
Vanguard Group Inc9.65%10,115,624$735.61MInstitution
Alta Biopharma Partners II LP9.53%9,982,720$725.94MInsider
G. Leonard Baker Jr.8.78%9,200,067$669.03MInsider
Ingalls Snyder LLC7.73%8,099,747$589.01MInstitution
Tench Coxe6.58%6,890,503$501.08MInsider
Joseph C. Cook Jr.6.46%6,765,805$492.01MInsider

1 of 3

CORT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CORT28.47%71.53%Net BuyingNet Buying
ROIV34.19%65.81%Net SellingNet Selling
HALO76.68%23.32%Net SellingNet Selling
MDGL22.95%77.05%Net SellingNet Selling
JAZZ25.39%74.61%Net SellingNet Selling

Corcept Therapeutics Stock Ownership FAQ

Who owns Corcept Therapeutics?

Corcept Therapeutics (NASDAQ: CORT) is owned by 72.96% institutional shareholders, 183.29% Corcept Therapeutics insiders, and 0.00% retail investors. Patrick G. Enright is the largest individual Corcept Therapeutics shareholder, owning 44.80M shares representing 42.76% of the company. Patrick G. Enright's Corcept Therapeutics shares are currently valued at $3.26B.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.